Company Filing History:
1 out of 8 
1 out of 5 Years Active: 2010
Title: Roberta Piva: Innovator in Synthetic Oligonucleotides
Introduction
Roberta Piva is a notable inventor based in Ferrara, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of synthetic oligonucleotides. Her work focuses on innovative solutions for treating osteopenic pathologies, which are critical for improving bone health.
Latest Patents
Roberta Piva holds a patent for "Double-stranded synthetic oligonucleotides useful for inducing apoptosis of osteoclasts for the treatment of osteopenic pathologies." This invention relates to a synthetic double-stranded oligonucleotide that modifies the molecular phenotype of osteoclasts and enhances the expression of the estrogen alpha receptor gene. The oligonucleotide is characterized by the sequence 5'-ATTTATTTTCAATACTGACT-3' (SEQ ID NO: 1) or its fragments or mutants. The pharmaceutical compositions derived from this oligonucleotide have therapeutic applications, particularly in treating osteopenic diseases such as osteoporosis.
Career Highlights
Throughout her career, Roberta Piva has been associated with esteemed institutions such as the University of Ferrara and the Venetian Association for the Fight Against Thalassemia. Her work has been instrumental in advancing research in her field and contributing to the understanding of osteoclast biology.
Collaborations
Roberta has collaborated with notable colleagues, including Roberto Gambari and Letizia Penolazzi. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Roberta Piva's contributions to the field of synthetic oligonucleotides represent a significant advancement in the treatment of osteopenic pathologies. Her innovative work continues to inspire future research and development in biotechnology.